MSTN and sarcopenia: Considering the negative effects of Mstn on muscle growth, clinical studies have been performed mainly to evaluate whether the block of Mstn signaling might improve muscle mass and performance status in patients with sarcopenia and muscular dystrophy [117], whereas no data are available on the vascular effects of Mstn inhibition.